Decent write up on TIS
"Tissue Therapies is positioned to take advantage of the growing diabetic, venous and pressure ulcers market with their ground breaking VitroGro treatment. commercialisation of VitroGro will significantly de-risk the company while providing analysts with certainty for re-ratings."
link
Might buy in the next few weeks, can see it moving higher on news.
- Forums
- ASX - By Stock
- TIS
- australia's next csl?
australia's next csl?, page-29
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online